Home  /  News  /  McAndrews News

McAndrews Attorneys Recognized Among the World’s Leading Patent Practitioners for Third Consecutive Year

Date: June 26, 2014 || McAndrews News

CHICAGO, IL - June 26, 2014 - McAndrews, Held & Malloy founding partner and ChairmanTimothy J. Malloy, along with shareholders Herbert D. Hart IIIEdward A. Mas II, and Nabeela Rasheed, Ph.D., were featured once again in Intellectual Asset Managementmagazine's (IAM) "IAM 1000: The World's Leading Patent Practitioners." All four attorneys, who are listed in the guide's litigation and prosecution categories, have contributed to the IP specialty law firm being able to "hold its own against some of the biggest names in patent litigation." Hart was also recognized as a leading attorney in the emerging field of AIA trials. 

To compile the rankings, IAM conducted extensive research over a five-month period in order to identify leaders in the intellectual property field. Attorneys qualified for the listing only if they received substantial positive feedback from both IP attorneys and in-house counsel.

According to IAM, McAndrews, Held & Malloy's "attention to detail, sound strategic decision-making and technical dexterity" contribute to its prominence as one of the nation's leading IP and complex technology law firms. In this year's guide, Malloy is described as a "studious...fair and likeable" trial attorney who can "effectively explain the law as well as technology to a judge and jury." Mas is praised for his long-term relationship with Abbott Labs, particularly the counsel he has provided for more than 20 years to successfully protect the global healthcare provider's competitive market advantage. 

On the prosecution side, Rasheed's and Hart's work was touted for its "watertight protection" for clients' "most prized inventions." Rasheed, who practices at the leading edge of biochemical science, was called "wonderfully smart" and an "outstanding biotechnologist." Hart was lauded for being "immensely generous with his knowledge" and for his deep understanding of post-issuance practice. 

Nationally recognized for his intellectual property litigation successes, Timothy J. Malloy has been involved in numerous multimillion dollar verdicts, awards and settlements and has served as lead counsel in trials throughout the country. Highlights of his career include arguing before the U.S. Supreme Court on behalf of Eli Lilly and Company, the leading case directed to the scope of patent protection for medical devices, obtaining a $166 million judgment for infringement and obtaining a $5 million award of attorney's fees for an exceptional case. Malloy has been repeatedly listed in Best Lawyers, and was featured in the inaugural IAM 1000: The World's Leading Patent Practitioners. He was also listed byChambers USA as one of the top IP trial lawyers in Illinois and characterized as an "Outstanding Trial Lawyer," and has been designated a Fellow of the Litigation Counsel of America, an honorary society comprised of less than one-half of one percent of American trial lawyers. 

Herbert D. Hart III has litigated cases before the Patent Trial and Appeal Board (PTAB) over several decades and in a wide range of technologies. A particular area of specialty has been cases in life science and chemical technologies.  He is a well-recognized PTAB practitioner, and he has served as an expert witness on interference practice. He has regularly spoken before clients, professional associations, and other audiences on PTAB trial practice, as well as on rulemaking under the post-grant provisions of the AIA. Hart has served on the American Intellectual Property Law Association's (AIPLA) Special Task Force on AIA Rulemaking and he was also appointed to the six-member Intellectual Property Owners Association/American Bar Association (ABA)/AIPLA Expert Committee on Regulations for Conducting New Post-Grant Review/Inter Partes Review Procedures (also known as the "Gang of 6"). He is widely published in the field of IP law and has provided commentary in numerous legal, business and scientific publications. Hart is also an associate editor and contributing author of the ABA book, ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators.  He contributes to the legal profession by serving in leadership positions in all three national intellectual property law associations.

Edward A. Mas II works with clients in a wide range of technologies, with a special emphasis on medical devices. His practice focuses on patent litigation and other complex technology-related litigation. One of his professional highlights includes securing a $166 million dollar victory for Advanced Cardiovascular Systems, Inc., which rates among the top patent damages awards of all time. During the past several years, Mas has successfully defended multiple patent infringement suits on behalf of Abbott Labs, in which sales of the accused products exceeded $1 billion. His most recent victory came in 2013, when the U.S. Court of Appeals unanimously affirmed a finding of patent invalidity in a case brought against Abbott by Johnson & Johnson subsidiary, Cordis. The case involved Abbott's market-leading drug-eluting stent. In addition to medical devices, Mas's litigation practice has involved such diverse technologies as pharmaceuticals, antibodies and related expression systems, barcode scanners and printers, bicycle equipment and automotive sensors. Mas also handles patent reexaminations and other proceedings in the United States Patent and Trademark Office, client counseling, licensing, clearance opinions and portfolio management.

At McAndrews, Held & Malloy, Nabeela Rasheed's, Ph.D., practice focuses on the acquisition and enforcement of intellectual property rights. She is the legal counselor of choice for companies seeking to identify, protect and maximize the value of their IP portfolios. Dr. Rasheed also advises clients in the acquisition and protection of intellectual property developed through joint ventures and strategic alliances, and conducts IP due diligence in relation to mergers, acquisitions and other transactions. She has extensive experience with opposition practice in the United States and Europe, and regularly represents clients in patent reexaminations, inter partes reviews and post-grant reviews. In addition, Dr. Rasheed serves as an independent consultant in matters involving inventorship and the prioritization of invention issues.

###

About McAndrews, Held & Malloy
McAndrews, Held & Malloy boasts one of the most highly regarded teams of intellectual property attorneys, agents and technology specialists in the United States. Founded in 1988, the firm offers deep bench strength in matters relating to patents, trademarks, copyrights, trade secrets and unfair competition. McAndrews attorneys have underlying scientific-based degrees and extensive prior experience in technology and IP-focused professions, and they routinely handle cases that involve innovative and cutting-edge technologies in specialized industries. While best known for their record of litigation successes, the firm also offers services in IP procurement, patent interferences, trademark oppositions and cancellations, IP/technology opinions and investigations, global portfolio management, development and licensing, M&A support, due diligence, design rights and joint ventures. Clients include multi-national corporations, Fortune 500 companies, startups and world-renowned universities. For more information, visit www.mcandrews-ip.com.